Literature DB >> 14696492

Aggressive recurrence after radiofrequency ablation of liver neoplasms.

Nazario Portolani1, Guido Alberto Massimo Tiberio, Maurizio Ronconi, Arianna Coniglio, Sara Ghidoni, Giacomo Gaverini, Stefano Maria Giulini.   

Abstract

Radiofrequency ablation is considered safe for inoperable liver neoplasms; with small lesions the rate of success is very high, the local recurrence is marginal and generally suitable for a retreatment. We have little information about the possibility of rapid regrowth of the tumor after a response judged as complete. We present four patients, affected by primary (3 patients) and metastatic (1 patient) uninodular cancer. All the lesions were small, superficial and well suited for surgery, but were treated by radiofrequency ablation elsewhere. The early instrumental evaluations stated a complete result in all the patients. Cancer regrowth was diagnosed at 3, 4, 6 and 12 months after radiofrequency ablation, always starting from the treated lesion. In case 1 the whole right lobe was involved together with a controlateral multinodular recurrence; cases 2 and 3 presented an extensive liver and parietal wall involvement; while in the fourth patient a diffuse biliary colonization was observed. Only 1 patient was suitable for surgery; the others died 6, 2 and 4 months, respectively, after recurrence. Recurrence after radiofrequency ablation may show an aggressive evolution precluding any possibility of cure. Radiofrequency ablation must not be considered a suitable alternative to surgery in patients with a low surgical risk.

Entities:  

Mesh:

Year:  2003        PMID: 14696492

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  19 in total

1.  Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver.

Authors:  Chiaki Kawamoto; Atsushi Yamauchi; Yoko Baba; Keiko Kaneko; Koji Yakabi
Journal:  J Gastroenterol       Date:  2009-11-20       Impact factor: 7.527

2.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Authors:  Shotaro Enomoto; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2011-01-09       Impact factor: 6.047

3.  Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma.

Authors:  Koichi Obara; Nobuyuki Matsumoto; Masaru Okamoto; Minoru Kobayashi; Hiroki Ikeda; Hideaki Takahashi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; Chiaki Okuse; Michihiro Suzuki; Fumio Itoh
Journal:  Hepatol Int       Date:  2008-01-29       Impact factor: 6.047

4.  Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma.

Authors:  Yoshiyuki Mori; Hideyuki Tamai; Naoki Shingaki; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Shotaro Enomoto; Hiroto Magari; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2009-04-29       Impact factor: 6.047

5.  Radiofrequency (RF)-assisted hepatectomy may induce severe postoperative liver damage.

Authors:  Miyazawa Mitsuo; Torii Takahiro; Toshimitsu Yasuko; Aikawa Masayasu; Okada Katsuya; Shinozuka Nozomi; Otani Yoshihide; Koyama Isamu
Journal:  World J Surg       Date:  2007-09-18       Impact factor: 3.352

6.  Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Koichi Okamoto; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Ichiro Onishi; Hiroyuki Takamura; Hirohisa Kitagawa; Sachio Fushida; Takashi Tani; Takashi Fujimura; Masato Kayahara; Kuniaki Arai; Tatsuya Yamashita; Shuichi Kaneko; Yoh Zen
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Authors:  Kosaku Moribata; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Tatsuya Shiraki; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Masao Ichinose
Journal:  World J Hepatol       Date:  2012-12-27

Review 8.  Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Kai Feng; Kuan-Sheng Ma
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.

Authors:  Hee Young Lee; Hyunchul Rhim; Min Woo Lee; Young-Sun Kim; Dongil Choi; Min Jung Park; Young Kon Kim; Seong Hyun Kim; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2012-10-20       Impact factor: 5.315

10.  Complete pathological response to transcatheter arterial infusion despite a rapidly progressing recurrent hepatocellular carcinoma with portal vein tumor thrombus: A case report.

Authors:  Masanobu Taguchi; Yasunaru Sakuma; Hideki Sasanuma; Naohiro Sata; Alan Kawarai Lefor; Takahiro Sasaki; Akira Tanaka; Yoshikazu Yasuda
Journal:  Int J Surg Case Rep       Date:  2015-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.